Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oracle Corporation (ORCL) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Oracle CorporationTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Oracle Corporation vs Vir Biotechnology Inc. Common Stock — how do they compare? Oracle Corporation trades at $128.14 (market cap $434.11B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Oracle Corporation is far larger — about 241.2× Vir Biotechnology Inc. Common Stock's market cap, and Oracle Corporation pays a 1.4% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oracle Corporation for 73 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

ORCLVIR
Market Cap
$434.11B$1.80B
Volume
25,917,5511,782,836
Sector
TechnologyHealth
52-Week High
$313.00$11.78
52-Week Low
$114.99$5.12
Typical Hold Time
73 Days0 Days
Enterprise Value
$557.92B$1.36B
Dividend Yield
1.4%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oracle Corporation

Oracle (ORCL) trades at $137.40, down 2.92% on the day amid a bearish technical signal, though it has consistently beaten earnings estimates in recent quarters. Revenue grew to $57.40B in 2025 with a net income margin of 26.36%, while analyst consensus remains strongly bullish with a $236.52 price target. Recent news highlights strong AI cloud demand and restructuring efforts to support growth.

The outlook is positive given robust fundamentals and AI-driven revenue acceleration, but risks include high debt levels, competitive pressures, and market volatility. The stock presents a long-term opportunity if execution on AI infrastructure continues, though near-term price weakness reflects investor caution.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ORCL
53% Buy47% Sell
Avg holding period · 73 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

Read more on ORCL →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →